At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FOXO FOXO Technologies Inc.
Not Yet Opened 12-30 16:00:00 EST Delay
FOXO Technologies Inc. Files Information Statement Detailing Authorized Corporate Actions
FOXO Technologies Inc. Announces Plans to Pursue Growth Through Healthcare Sector Acquisitions, Expansion of Operating Subsidiaries, and Investment in Pharmaceutical Services Business
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.